Israel’s aMoon Joins $110 Million Investment In SOPHIA GENETICS
We’ve come a long way in Israel since the days when the country depended on every dime from tourism and the export of oranges. Sophia Genetics, a Swiss Medtech company, raised $110 Million in a series F financing round which was led by an Israeli venture capital firm aMoon, an Israel based life sciences venture […]
Continue Reading